Drugs / bOPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03821441 | Jan 2018 → May 2020 | poliomyelitis | Chinese Academy of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03821441 ↗ |
| Modality | Vaccine | “bivalent oral attenuated live poliomyelitis vaccine against type 1 and type 3” NCT03821441 ↗ |
| Route | Oral | “A single dose of 1 pill orally of bOPV” NCT03821441 ↗ |